DK0920330T3 - hCG og derivater som inhibitorer af matrixmetalloproteaser - Google Patents
hCG og derivater som inhibitorer af matrixmetalloproteaserInfo
- Publication number
- DK0920330T3 DK0920330T3 DK97934545T DK97934545T DK0920330T3 DK 0920330 T3 DK0920330 T3 DK 0920330T3 DK 97934545 T DK97934545 T DK 97934545T DK 97934545 T DK97934545 T DK 97934545T DK 0920330 T3 DK0920330 T3 DK 0920330T3
- Authority
- DK
- Denmark
- Prior art keywords
- hcg
- inhibitors
- derivatives
- matrix metalloproteases
- metalloproteases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Ophthalmology & Optometry (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT96RM000566A IT1284876B1 (it) | 1996-08-07 | 1996-08-07 | Hcg come inibitore della collagenasi |
PCT/EP1997/004053 WO1998005353A1 (fr) | 1996-08-07 | 1997-07-25 | hCG ET SES DERIVES COMME INHIBITEURS DE METALLOPROTEASES DE MATRICE |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0920330T3 true DK0920330T3 (da) | 2002-12-30 |
Family
ID=11404385
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97934545T DK0920330T3 (da) | 1996-08-07 | 1997-07-25 | hCG og derivater som inhibitorer af matrixmetalloproteaser |
Country Status (14)
Country | Link |
---|---|
US (1) | US6444639B2 (fr) |
EP (1) | EP0920330B1 (fr) |
JP (1) | JP3996952B2 (fr) |
AR (1) | AR009013A1 (fr) |
AT (1) | ATE228372T1 (fr) |
AU (1) | AU732972B2 (fr) |
CA (1) | CA2262582C (fr) |
DE (1) | DE69717463T2 (fr) |
DK (1) | DK0920330T3 (fr) |
ES (1) | ES2183205T3 (fr) |
IL (1) | IL128399A (fr) |
IT (1) | IT1284876B1 (fr) |
PT (1) | PT920330E (fr) |
WO (1) | WO1998005353A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006516548A (ja) | 2002-12-30 | 2006-07-06 | アンジオテック インターナショナル アクツィエン ゲゼルシャフト | 迅速ゲル化ポリマー組成物からの薬物送達法 |
ATE556716T1 (de) | 2004-02-13 | 2012-05-15 | Stem Cell Therapeutics Corp | Verwendung des luteinisierenden hormons (lh) und von choriongonadotrophin (hcg) für die proliferation von neuralen stammzellen und neurogenese |
CA2582567A1 (fr) | 2004-10-07 | 2006-04-13 | Stem Cell Therapeutics Corp. | Stimulation de la proliferation de cellules souches pluripotentes par administration de composes associes a la gestation |
EP2004212A4 (fr) | 2006-03-17 | 2010-07-14 | Stem Cell Therapeutics Corp | Régimes de dosage continu pour agents de prolifération des cellules souches nerveuses et agents de différentiation desdites cellules |
EP3177316B1 (fr) * | 2014-07-15 | 2019-05-08 | Zietchick Research Institute, LLC | Procédé de prévention ou de traitement de troubles oculaires |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1250075B (it) * | 1991-12-18 | 1995-03-30 | Serono Cesare Ist Ricerca | Composizioni farmaceutiche contenenti gonadotropine. |
US5677275A (en) * | 1994-08-05 | 1997-10-14 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment of cancer with human chorionic gonadotropin |
US6251402B1 (en) * | 1995-10-16 | 2001-06-26 | Applied Research Systems Ars Holding N.V. | Use of human chorionic gonadotropin in the treatment of Kaposi's sarcoma |
US5968513A (en) * | 1996-06-24 | 1999-10-19 | University Of Maryland Biotechnology Institute | Method of promoting hematopoiesis using derivatives of human chorionic gonadotropin |
-
1996
- 1996-08-07 IT IT96RM000566A patent/IT1284876B1/it active IP Right Grant
-
1997
- 1997-07-25 CA CA002262582A patent/CA2262582C/fr not_active Expired - Fee Related
- 1997-07-25 JP JP50755698A patent/JP3996952B2/ja not_active Expired - Fee Related
- 1997-07-25 PT PT97934545T patent/PT920330E/pt unknown
- 1997-07-25 EP EP97934545A patent/EP0920330B1/fr not_active Expired - Lifetime
- 1997-07-25 AT AT97934545T patent/ATE228372T1/de active
- 1997-07-25 WO PCT/EP1997/004053 patent/WO1998005353A1/fr active IP Right Grant
- 1997-07-25 ES ES97934545T patent/ES2183205T3/es not_active Expired - Lifetime
- 1997-07-25 DK DK97934545T patent/DK0920330T3/da active
- 1997-07-25 US US09/242,099 patent/US6444639B2/en not_active Expired - Lifetime
- 1997-07-25 AU AU37711/97A patent/AU732972B2/en not_active Ceased
- 1997-07-25 IL IL128399A patent/IL128399A/en not_active IP Right Cessation
- 1997-07-25 DE DE69717463T patent/DE69717463T2/de not_active Expired - Lifetime
- 1997-08-06 AR ARP970103577A patent/AR009013A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU732972B2 (en) | 2001-05-03 |
WO1998005353A1 (fr) | 1998-02-12 |
ATE228372T1 (de) | 2002-12-15 |
EP0920330A1 (fr) | 1999-06-09 |
CA2262582C (fr) | 2009-02-24 |
IL128399A0 (en) | 2000-01-31 |
IL128399A (en) | 2006-10-05 |
PT920330E (pt) | 2003-02-28 |
ITRM960566A1 (it) | 1998-02-07 |
JP3996952B2 (ja) | 2007-10-24 |
AR009013A1 (es) | 2000-03-08 |
US6444639B2 (en) | 2002-09-03 |
DE69717463D1 (de) | 2003-01-09 |
CA2262582A1 (fr) | 1998-02-12 |
IT1284876B1 (it) | 1998-05-22 |
JP2000516582A (ja) | 2000-12-12 |
US20010006940A1 (en) | 2001-07-05 |
EP0920330B1 (fr) | 2002-11-27 |
AU3771197A (en) | 1998-02-25 |
ES2183205T3 (es) | 2003-03-16 |
ITRM960566A0 (fr) | 1996-08-07 |
DE69717463T2 (de) | 2003-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO991922D0 (no) | Heteroarylsuccinamider og deres anvendelse som metalloproteinaseinhibitorer | |
DK0923585T3 (da) | Phosphinatbaserede inhibitorer af matrixmetalloproteinaser | |
DK0938471T3 (da) | Fremstillingen og anvendelsen af ortho-sulfonamido-arylhydroxamsyrer som matrix-metalloproteinase- og TACE-inhibitorer | |
DK0944590T3 (da) | Aminoguanidiner og alkoxyguanidiner som proteaseinhibitorer | |
FI962315A (fi) | Entsyymi-inhibiittorit | |
DK0922697T3 (da) | Substituerede pyrazolylbenzensulfonamider og anvendelse deraf som cyclooxygenase II-inhibitorer | |
DE69718480T2 (de) | Heterocyclische metalloprotease inhibitoren | |
DK1133477T3 (da) | Substituerede benzimidazoler og deres anvendelse som parpinhibitorer | |
ID18416A (id) | Inhibitor metaloprotease diheterosiklik | |
NO972307D0 (no) | Matriksmetallproteaseinhibitorer | |
DK0934301T3 (da) | Aminothiophencarboxylsyreamider og anvendelse deraf som phosphodiesteraseinhibitorer | |
NO986180D0 (no) | Nye amidinoderivater og deres anvendelse som trombininhibitorer | |
NO996313D0 (no) | Nye amidinoderivater og deres anvendelse som trombininhibitorer | |
DK0934259T3 (da) | Beta-sulfonamidohydroxamsyrer som matrixmetalloproteinase- og TACE-inhibitorer | |
DK1047450T3 (da) | Kombinationer af ACE-inhibitorer og MMP-inhibitorer | |
NO974403L (no) | Reversible proteasehemmere | |
NO984761D0 (no) | Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler | |
ID17792A (id) | Penghambat penghambat metaloproreinase matriks | |
NO995513D0 (no) | N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK-A agonister | |
NO991316D0 (no) | 3-mercaptoacetylamino-1,5-substituerte-2-okso-azepanderivater som er anvendbare som inhibitorer av matriksmetalloproteinase | |
DK0888316T3 (da) | 2-(3H)-oxazolonderivater og deres anvendelse som cox-2 inhibitorer | |
DK1047665T3 (da) | Matrix metalloprotease inhibitorer | |
DK1214302T3 (da) | Substituerede 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-oner og deres anvendelse som lipasehæmmere | |
TR199501429A2 (tr) | Matriks metaloproteaz inhibitörlerinin yerine gecen 4-biarilpentanoik asitleri ve türevleri | |
NO954321L (no) | 4-aryl-4-hydroksy-tetrahydropyraner og 3-aryl-3-hydroksy-tetrahydrofuraner som 5-lipoksygenase-inhibitorer |